ICP
RMD icon

Interchange Capital Partners’s ResMed RMD Stock Holding History

Interchange Capital Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-849
Closed -$232K – 450
2025
Q3 		$232K Buy
+849
New +$232K 0.05% 319
2021
Q1 		– Sell
-53
Closed -$11K – 915
2020
Q4 		$11K Buy
+53
New +$10.6K 0.01% 775

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Interchange Capital Partners's RMD Position: Q4 2025 in Review

Interchange Capital Partners sold out of ResMed (RMD) in Q4 2025, closing a stake of 849 shares — an estimated $232K sold.

Interchange Capital Partners first reported a position in RMD in Q4 2020 and held it in 2 quarters. The position peaked at $232K in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Interchange Capital Partners reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Interchange Capital Partners sold 849 ResMed shares in Q4 2025, an estimated $232K.
  • Interchange Capital Partners first reported a position in ResMed in Q4 2020 and held it in 2 quarters.
  • Interchange Capital Partners's ResMed position peaked at $232K in Q3 2025.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Interchange Capital Partners's 13F filing for Q4 2025, filed 30 Jan 2026.